Bolt Biotherapeutics, Inc. · NASDAQ:BOLT
Yonehiro Grant sold 13,176 Bolt Biotherapeutics, Inc. shares (Form 4)
Traded Sep 16 to Sep 18, 2026 · Filed Sep 21, 2026
From Sep 16 to Sep 18, 2026, Yonehiro Grant (Chief Operating Officer) sold 13,176 Bolt Biotherapeutics, Inc. shares at an average US$3.33 for US$43,834, leaving 17,269 shares. Filed Sep 21, 2026 (Form 4).
- Sold
- 13,176 shares
- Price
- US$3.33 average (US$3.24 to US$3.77)
- Value
- US$43,834
- Holding after
- 17,269 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | Sale | 1,417 | US$3.77 | 29,028 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 4,909 | US$3.32 | 24,119 | Direct |
| Sep 18, 2026 | Common Stock | Sale | 6,850 | US$3.24 | 17,269 | Direct |
Source
Related
- Bolt Biotherapeutics, Inc.
- Yonehiro Grant
- Bolt Biotherapeutics, Inc. shareholders
- Form 4 · Nemec Sarah · Sep 21, 2026
- Form 4 · Quinn William P. · Sep 21, 2026
- Schedule 13G · Renaissance Technologies LLC · Aug 13, 2026
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 26, 2026
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 17, 2026